Source: LHGDN

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 596
Gene Symbol: BCL2
BCL2
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Biomarker LHGDN Bcl-2 mediated modulation of vascularization in prostate cancer xenografts. 19107861

2009
Entrez Id: 596
Gene Symbol: BCL2
BCL2
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 AlteredExpression LHGDN Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate. 18573594

2008
Entrez Id: 596
Gene Symbol: BCL2
BCL2
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 GeneticVariation LHGDN Germline BCL-2 sequence variants and inherited predisposition to prostate cancer. 16733517

2006
Entrez Id: 596
Gene Symbol: BCL2
BCL2
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 AlteredExpression LHGDN Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cells. 12629413

2003
Entrez Id: 596
Gene Symbol: BCL2
BCL2
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 PosttranslationalModification LHGDN Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation. 11839683

2002
Entrez Id: 596
Gene Symbol: BCL2
BCL2
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Biomarker LHGDN Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. 12086875

2002
Entrez Id: 596
Gene Symbol: BCL2
BCL2
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 AlteredExpression LHGDN BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agents. 11776759

2001